Peptide glossary · Reading the research
Double-blind
Checked against NCI Dictionary of Cancer Terms (National Cancer Institute)Published by PepVault
A double-blind trial is one in which neither the people taking part nor the researchers know who gets the treatment until the trial is over.
What it means
Keeping both sides blind makes the result less likely to be swayed by what people expect. The large GLP-1 trials in the library, such as tirzepatide’s SURMOUNT-1, were double-blind.
Why it matters when you track peptides
A double-blind result counts for more than a report from an open study, because expectation can change how people feel.

Where you meet it
Checked against
NCI Dictionary of Cancer Terms (National Cancer Institute), “double-blind study”